6534 — CH Biotech R&D Co Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedSmall CapNeutral

Annual balance sheet for CH Biotech R&D Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	324	321	530	943	482
Net Total Accounts Receivable
Net Total Receivables	36.5	161	33.8	106	164
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	442	655	804	1,235	853
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,390	2,358	2,365	2,361	2,718
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,879	3,029	3,195	3,649	3,629
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	450	529	468	882	647
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,399	1,306	1,108	1,129	983
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,480	1,723	2,088	2,520	2,646
Total Liabilities & Shareholders' Equity	2,879	3,029	3,195	3,649	3,629
Total Common Shares Outstanding